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Background
Recent evidence has given importance to heterogenous
scar areas (HSA) in the identification of patients receiving
appropriate implantable-cardioverter-defibrillator (ICD)
therapy (Rayatzadeh, JCMR 2013;15:31). Late gadolinium
enhancement (LGE) CMR has the potential of becoming
one of the main tools for risk stratification in patients
affected by hypertrophic cardiomyopathy (HCM). While
visual analysis of LGE is commonly used for clinical
reporting, quantitative LGE analysis has been used in
several clinical studies. The aim of this study was to evalu-
ate the presence of HSA in patients with HCM and to
compare the findings in this group with patients with
myocardial infarct (MI) and subject with normal CMR
scan.
Methods
72 consecutive patients with known HCM, 10 patients
with normal CMR findings and no history of myocardial
infarction or HC, and 12 patients with previous MI and
preserved global left ventricular function (EF > 55%)
were included. Scar size was determined using thresh-
olds of 2 and 5 SD above remote normal myocardium
and by visual assessment. HSA was defined as the region
between 2 and 5 SD.
Results
Out of the 94 patients in this study there was significant
accordance between visual and quantitative assessment for
LGE. The amount of HSA was significantly higher in HCM
(27.9% ± 9%) than in MI (18.6% ± 4.7%; p < 0.01) and in
normal subjects (15.1% ± 6.0%; p < 0.01). No significant
differences in the HSA were observed between MI and
normal groups (p = 0.67). Moreover a linear correlation
between the amount of HSA and the amount of LGE
volume detected at 5 SD threshold was found.
Conclusions
Our results confirm the potential usefulness of HSA in
patients with HCM. Differently from patients with
previous MI and normal LV ejection fraction - where LGE
constitutes a discrete and localised lesion - and differently
from subject with normal CMR scan, patient with HCM
has significant amounts of HSA on quantitative analysis.
Although more studies will be needed to clarify the poten-
tial for a clinical use of HSA, the most likely pathophysio-
logical substrate to explain our findings is a direct
relationship between HSA and interstitial fibrosis. If this is
confirmed, HSA could represent a novel predictor of
adverse outcomes in HCM patients and help for improved
risk stratification in a clinical setting.
Funding
The Centre of Excellence in Medical Engineering is
funded by the Wellcome Trust and EPSRC under grant
number WT 088641/Z/09/Z. The authors acknowledge
financial support from the Department of Health via the
National Institute for Health Research (NIHR) compre-
hensive Biomedical Research Centre award to Guy’s and
St Thomas’ NHS Foundation Trust in partnership with
King’s College London.
Authors’ details
1Cardiovascular Imaging, King’s College London, London, UK. 2Internal
Medicine, University of Genoa, Genoa, Italy.
1Cardiovascular Imaging, King’s College London, London, UK
Full list of author information is available at the end of the article
Vianello et al. Journal of Cardiovascular Magnetic
Resonance 2014, 16(Suppl 1):P369
http://www.jcmr-online.com/content/16/S1/P369
© 2014 Vianello et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Published: 16 January 2014
doi:10.1186/1532-429X-16-S1-P369
Cite this article as: Vianello et al.: Scar heterogeneity in hypertrophic
cardiomyopathy. Comparison with chronic myocardial infarction and
normal subjects. Journal of Cardiovascular Magnetic Resonance 2014 16
(Suppl 1):P369.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Vianello et al. Journal of Cardiovascular Magnetic
Resonance 2014, 16(Suppl 1):P369
http://www.jcmr-online.com/content/16/S1/P369
Page 2 of 2
